Let's talk medical research

Facebook has over 2 billion daily users, making it one of the most effective ways clinical research recruitment agencies share clinical trial opportunities with patients. But the platform isn't always intuitive, and small mistakes can lead your ads to be rejected, or reach the wrong audience.

Obesity is a common condition, impacting nearly 3 in 4 adults over the age of 20 in the United States. Research into obesity medications has increased significantly in recent years, resulting in novel weight-management drugs that are continuing to drive interest and demand. However, although obesity disproportionately impacts people of color, many of these studies are still made up of ...

Obesity, a medical condition characterized by an increased amount of body fat, impacts nearly 3 in 4 adults over the age of 20 in the United States. Most commonly defined as a Body Mass Index (BMI) over 30, it is a chronic condition that can negatively impact many aspects of a person’s health.

Though clinical trials are often discussed in the context of medications and therapies, the devices that administer these medications must also be approved by the FDA before they can be released to market. This requirement includes tools patients and medical professionals use, such as inhalers, insulin injectors, auto-injectors for epinephrine, and devices that administer injectable medications.

When recruiting patients for a clinical trial, using data is one of the best ways to make informed decisions about study management. From understanding where patients are in the funnel to which sites are receiving too much volume, accessing the metrics that drive these decisions should be simple — and with Antidote’s Pulse™ software, it is.

Antidote was thrilled to attend the 2024 DIA Conference in San Diego last week! Not only was it a lovely opportunity to connect with many industry professionals and learn from experts, but it was also the celebration of 60 years of DIA. In case you missed it, we’re sharing some of our key takeaways from the four-day event, which focused on charting new horizons in clinical trials.

Though collecting accurate data, keeping precise records, and measuring results are all complex tasks involved with medical research, clinical trial recruitment and enrollment are often cited as the most challenging part of the process. Not only is having a large enough sample size essential for research integrity, but recruitment delays can also be extremely costly. By some estimates, delays in ...

Recruiting and retaining patients are two of the most challenging aspects of clinical trials. The average clinical trial must extend its recruitment timeline by 71%, and up to 30% of patients will eventually drop out. While patients can leave a trial if it is not a good fit for them, there are patient-centric approaches that can make enrolling and participating in a study a more enjoyable ...

Diversity is an essential aspect of medical research for many reasons. Ensuring equitable access to healthcare is vital, as it is a critical component of understanding the efficacy of potential new treatments and can improve the overall health of all individuals.

For medications to work effectively for all who need them, clinical trials need to include a diverse cross-section of the population. However, although nearly 40% of the United States population is racial and ethnic minorities, estimated rates of research participation for these groups range from just 2% to 16%.